Pre-order Enquiry
Request Free Sample
Global Herpes Simplex Virus Infection Treatment Market Size, Status and Forecast 2021-2027
SKU ID : QYR-17719572 | Publishing Date : 18-Mar-2021
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Herpes Simplex Virus Infection Treatment Market Size, Status and Forecast 2021-2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Herpes Simplex Virus Infection Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Herpes Simplex Virus-1 (HSV-1) Infection
1.2.3 Herpes Simplex Virus-2 (HSV-2) Infection
1.2.4 HSV1 & HSV2 Co-infection
1.3 Market by Application
1.3.1 Global Herpes Simplex Virus Infection Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Herpes Simplex Virus Infection Treatment Market Perspective (2016-2027)
2.2 Herpes Simplex Virus Infection Treatment Growth Trends by Regions
2.2.1 Herpes Simplex Virus Infection Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Herpes Simplex Virus Infection Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Herpes Simplex Virus Infection Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Herpes Simplex Virus Infection Treatment Industry Dynamic
2.3.1 Herpes Simplex Virus Infection Treatment Market Trends
2.3.2 Herpes Simplex Virus Infection Treatment Market Drivers
2.3.3 Herpes Simplex Virus Infection Treatment Market Challenges
2.3.4 Herpes Simplex Virus Infection Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Herpes Simplex Virus Infection Treatment Players by Revenue
3.1.1 Global Top Herpes Simplex Virus Infection Treatment Players by Revenue (2016-2021)
3.1.2 Global Herpes Simplex Virus Infection Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Herpes Simplex Virus Infection Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Herpes Simplex Virus Infection Treatment Revenue
3.4 Global Herpes Simplex Virus Infection Treatment Market Concentration Ratio
3.4.1 Global Herpes Simplex Virus Infection Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Herpes Simplex Virus Infection Treatment Revenue in 2020
3.5 Herpes Simplex Virus Infection Treatment Key Players Head office and Area Served
3.6 Key Players Herpes Simplex Virus Infection Treatment Product Solution and Service
3.7 Date of Enter into Herpes Simplex Virus Infection Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Herpes Simplex Virus Infection Treatment Breakdown Data by Type
4.1 Global Herpes Simplex Virus Infection Treatment Historic Market Size by Type (2016-2021)
4.2 Global Herpes Simplex Virus Infection Treatment Forecasted Market Size by Type (2022-2027)
5 Herpes Simplex Virus Infection Treatment Breakdown Data by Application
5.1 Global Herpes Simplex Virus Infection Treatment Historic Market Size by Application (2016-2021)
5.2 Global Herpes Simplex Virus Infection Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Herpes Simplex Virus Infection Treatment Market Size (2016-2027)
6.2 North America Herpes Simplex Virus Infection Treatment Market Size by Type
6.2.1 North America Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2021)
6.2.2 North America Herpes Simplex Virus Infection Treatment Market Size by Type (2022-2027)
6.2.3 North America Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2027)
6.3 North America Herpes Simplex Virus Infection Treatment Market Size by Application
6.3.1 North America Herpes Simplex Virus Infection Treatment Market Size by Application (2016-2021)
6.3.2 North America Herpes Simplex Virus Infection Treatment Market Size by Application (2022-2027)
6.3.3 North America Herpes Simplex Virus Infection Treatment Market Size by Application (2016-2027)
6.4 North America Herpes Simplex Virus Infection Treatment Market Size by Country
6.4.1 North America Herpes Simplex Virus Infection Treatment Market Size by Country (2016-2021)
6.4.2 North America Herpes Simplex Virus Infection Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Herpes Simplex Virus Infection Treatment Market Size (2016-2027)
7.2 Europe Herpes Simplex Virus Infection Treatment Market Size by Type
7.2.1 Europe Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2021)
7.2.2 Europe Herpes Simplex Virus Infection Treatment Market Size by Type (2022-2027)
7.2.3 Europe Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2027)
7.3 Europe Herpes Simplex Virus Infection Treatment Market Size by Application
7.3.1 Europe Herpes Simplex Virus Infection Treatment Market Size by Application (2016-2021)
7.3.2 Europe Herpes Simplex Virus Infection Treatment Market Size by Application (2022-2027)
7.3.3 Europe Herpes Simplex Virus Infection Treatment Market Size by Application (2016-2027)
7.4 Europe Herpes Simplex Virus Infection Treatment Market Size by Country
7.4.1 Europe Herpes Simplex Virus Infection Treatment Market Size by Country (2016-2021)
7.4.2 Europe Herpes Simplex Virus Infection Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size (2016-2027)
8.2 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Type
8.2.1 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Application
8.3.1 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Region
8.4.1 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Herpes Simplex Virus Infection Treatment Market Size (2016-2027)
9.2 Latin America Herpes Simplex Virus Infection Treatment Market Size by Type
9.2.1 Latin America Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Herpes Simplex Virus Infection Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2027)
9.3 Latin America Herpes Simplex Virus Infection Treatment Market Size by Application
9.3.1 Latin America Herpes Simplex Virus Infection Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Herpes Simplex Virus Infection Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Herpes Simplex Virus Infection Treatment Market Size by Application (2016-2027)
9.4 Latin America Herpes Simplex Virus Infection Treatment Market Size by Country
9.4.1 Latin America Herpes Simplex Virus Infection Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Herpes Simplex Virus Infection Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size (2016-2027)
10.2 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Type
10.2.1 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Application
10.3.1 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Country
10.4.1 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche Ltd
11.1.1 F. Hoffmann-La Roche Ltd Company Details
11.1.2 F. Hoffmann-La Roche Ltd Business Overview
11.1.3 F. Hoffmann-La Roche Ltd Herpes Simplex Virus Infection Treatment Introduction
11.1.4 F. Hoffmann-La Roche Ltd Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
11.1.5 F. Hoffmann-La Roche Ltd Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Herpes Simplex Virus Infection Treatment Introduction
11.2.4 Sanofi Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
11.2.5 Sanofi Recent Development
11.3 Teva Pharmaceuticals Inc
11.3.1 Teva Pharmaceuticals Inc Company Details
11.3.2 Teva Pharmaceuticals Inc Business Overview
11.3.3 Teva Pharmaceuticals Inc Herpes Simplex Virus Infection Treatment Introduction
11.3.4 Teva Pharmaceuticals Inc Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
11.3.5 Teva Pharmaceuticals Inc Recent Development
11.4 Merck & Co., Inc
11.4.1 Merck & Co., Inc Company Details
11.4.2 Merck & Co., Inc Business Overview
11.4.3 Merck & Co., Inc Herpes Simplex Virus Infection Treatment Introduction
11.4.4 Merck & Co., Inc Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
11.4.5 Merck & Co., Inc Recent Development
11.5 Apotex Inc
11.5.1 Apotex Inc Company Details
11.5.2 Apotex Inc Business Overview
11.5.3 Apotex Inc Herpes Simplex Virus Infection Treatment Introduction
11.5.4 Apotex Inc Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
11.5.5 Apotex Inc Recent Development
11.6 Viatris
11.6.1 Viatris Company Details
11.6.2 Viatris Business Overview
11.6.3 Viatris Herpes Simplex Virus Infection Treatment Introduction
11.6.4 Viatris Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
11.6.5 Viatris Recent Development
11.7 Epi Health LLC
11.7.1 Epi Health LLC Company Details
11.7.2 Epi Health LLC Business Overview
11.7.3 Epi Health LLC Herpes Simplex Virus Infection Treatment Introduction
11.7.4 Epi Health LLC Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
11.7.5 Epi Health LLC Recent Development
11.8 Zydus Pharmaceuticals
11.8.1 Zydus Pharmaceuticals Company Details
11.8.2 Zydus Pharmaceuticals Business Overview
11.8.3 Zydus Pharmaceuticals Herpes Simplex Virus Infection Treatment Introduction
11.8.4 Zydus Pharmaceuticals Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
11.8.5 Zydus Pharmaceuticals Recent Development
11.9 GlaxoSmithKline LLC
11.9.1 GlaxoSmithKline LLC Company Details
11.9.2 GlaxoSmithKline LLC Business Overview
11.9.3 GlaxoSmithKline LLC Herpes Simplex Virus Infection Treatment Introduction
11.9.4 GlaxoSmithKline LLC Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
11.9.5 GlaxoSmithKline LLC Recent Development
11.10 Carlsbad Tech
11.10.1 Carlsbad Tech Company Details
11.10.2 Carlsbad Tech Business Overview
11.10.3 Carlsbad Tech Herpes Simplex Virus Infection Treatment Introduction
11.10.4 Carlsbad Tech Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
11.10.5 Carlsbad Tech Recent Development
11.11 Avet Pharmaceuticals Inc
11.11.1 Avet Pharmaceuticals Inc Company Details
11.11.2 Avet Pharmaceuticals Inc Business Overview
11.11.3 Avet Pharmaceuticals Inc Herpes Simplex Virus Infection Treatment Introduction
11.11.4 Avet Pharmaceuticals Inc Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
11.11.5 Avet Pharmaceuticals Inc Recent Development
11.12 Glenmark Pharmaceuticals
11.12.1 Glenmark Pharmaceuticals Company Details
11.12.2 Glenmark Pharmaceuticals Business Overview
11.12.3 Glenmark Pharmaceuticals Herpes Simplex Virus Infection Treatment Introduction
11.12.4 Glenmark Pharmaceuticals Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
11.12.5 Glenmark Pharmaceuticals Recent Development
11.13 Fresenius Kabi
11.13.1 Fresenius Kabi Company Details
11.13.2 Fresenius Kabi Business Overview
11.13.3 Fresenius Kabi Herpes Simplex Virus Infection Treatment Introduction
11.13.4 Fresenius Kabi Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
11.13.5 Fresenius Kabi Recent Development
11.14 Agenus, Inc
11.14.1 Agenus, Inc Company Details
11.14.2 Agenus, Inc Business Overview
11.14.3 Agenus, Inc Herpes Simplex Virus Infection Treatment Introduction
11.14.4 Agenus, Inc Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
11.14.5 Agenus, Inc Recent Development
11.15 Maruho Co. Ltd
11.15.1 Maruho Co. Ltd Company Details
11.15.2 Maruho Co. Ltd Business Overview
11.15.3 Maruho Co. Ltd Herpes Simplex Virus Infection Treatment Introduction
11.15.4 Maruho Co. Ltd Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
11.15.5 Maruho Co. Ltd Recent Development
11.16 AiCuris Anti-infective Cures GmbH
11.16.1 AiCuris Anti-infective Cures GmbH Company Details
11.16.2 AiCuris Anti-infective Cures GmbH Business Overview
11.16.3 AiCuris Anti-infective Cures GmbH Herpes Simplex Virus Infection Treatment Introduction
11.16.4 AiCuris Anti-infective Cures GmbH Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021)
11.16.5 AiCuris Anti-infective Cures GmbH Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Herpes Simplex Virus Infection Treatment Market Size, Status and Forecast 2021-2027
List of TablesTable 1. Global Herpes Simplex Virus Infection Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Herpes Simplex Virus-1 (HSV-1) Infection
Table 3. Key Players of Herpes Simplex Virus-2 (HSV-2) Infection
Table 4. Key Players of HSV1 & HSV2 Co-infection
Table 5. Global Herpes Simplex Virus Infection Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Herpes Simplex Virus Infection Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Herpes Simplex Virus Infection Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Herpes Simplex Virus Infection Treatment Market Share by Regions (2016-2021)
Table 9. Global Herpes Simplex Virus Infection Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Herpes Simplex Virus Infection Treatment Market Share by Regions (2022-2027)
Table 11. Herpes Simplex Virus Infection Treatment Market Trends
Table 12. Herpes Simplex Virus Infection Treatment Market Drivers
Table 13. Herpes Simplex Virus Infection Treatment Market Challenges
Table 14. Herpes Simplex Virus Infection Treatment Market Restraints
Table 15. Global Herpes Simplex Virus Infection Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Herpes Simplex Virus Infection Treatment Market Share by Players (2016-2021)
Table 17. Global Top Herpes Simplex Virus Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herpes Simplex Virus Infection Treatment as of 2020)
Table 18. Ranking of Global Top Herpes Simplex Virus Infection Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Herpes Simplex Virus Infection Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Herpes Simplex Virus Infection Treatment Product Solution and Service
Table 22. Date of Enter into Herpes Simplex Virus Infection Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Herpes Simplex Virus Infection Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Herpes Simplex Virus Infection Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Herpes Simplex Virus Infection Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Herpes Simplex Virus Infection Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Herpes Simplex Virus Infection Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Herpes Simplex Virus Infection Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Herpes Simplex Virus Infection Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Herpes Simplex Virus Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Herpes Simplex Virus Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Herpes Simplex Virus Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Herpes Simplex Virus Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Herpes Simplex Virus Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Herpes Simplex Virus Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Herpes Simplex Virus Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Herpes Simplex Virus Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Herpes Simplex Virus Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Herpes Simplex Virus Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Herpes Simplex Virus Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Herpes Simplex Virus Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Herpes Simplex Virus Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Herpes Simplex Virus Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Herpes Simplex Virus Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. F. Hoffmann-La Roche Ltd Company Details
Table 63. F. Hoffmann-La Roche Ltd Business Overview
Table 64. F. Hoffmann-La Roche Ltd Herpes Simplex Virus Infection Treatment Product
Table 65. F. Hoffmann-La Roche Ltd Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021) & (US$ Million)
Table 66. F. Hoffmann-La Roche Ltd Recent Development
Table 67. Sanofi Company Details
Table 68. Sanofi Business Overview
Table 69. Sanofi Herpes Simplex Virus Infection Treatment Product
Table 70. Sanofi Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021) & (US$ Million)
Table 71. Sanofi Recent Development
Table 72. Teva Pharmaceuticals Inc Company Details
Table 73. Teva Pharmaceuticals Inc Business Overview
Table 74. Teva Pharmaceuticals Inc Herpes Simplex Virus Infection Treatment Product
Table 75. Teva Pharmaceuticals Inc Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021) & (US$ Million)
Table 76. Teva Pharmaceuticals Inc Recent Development
Table 77. Merck & Co., Inc Company Details
Table 78. Merck & Co., Inc Business Overview
Table 79. Merck & Co., Inc Herpes Simplex Virus Infection Treatment Product
Table 80. Merck & Co., Inc Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021) & (US$ Million)
Table 81. Merck & Co., Inc Recent Development
Table 82. Apotex Inc Company Details
Table 83. Apotex Inc Business Overview
Table 84. Apotex Inc Herpes Simplex Virus Infection Treatment Product
Table 85. Apotex Inc Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021) & (US$ Million)
Table 86. Apotex Inc Recent Development
Table 87. Viatris Company Details
Table 88. Viatris Business Overview
Table 89. Viatris Herpes Simplex Virus Infection Treatment Product
Table 90. Viatris Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021) & (US$ Million)
Table 91. Viatris Recent Development
Table 92. Epi Health LLC Company Details
Table 93. Epi Health LLC Business Overview
Table 94. Epi Health LLC Herpes Simplex Virus Infection Treatment Product
Table 95. Epi Health LLC Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021) & (US$ Million)
Table 96. Epi Health LLC Recent Development
Table 97. Zydus Pharmaceuticals Company Details
Table 98. Zydus Pharmaceuticals Business Overview
Table 99. Zydus Pharmaceuticals Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021) & (US$ Million)
Table 100. Zydus Pharmaceuticals Recent Development
Table 101. GlaxoSmithKline LLC Company Details
Table 102. GlaxoSmithKline LLC Business Overview
Table 103. GlaxoSmithKline LLC Herpes Simplex Virus Infection Treatment Product
Table 104. GlaxoSmithKline LLC Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021) & (US$ Million)
Table 105. GlaxoSmithKline LLC Recent Development
Table 106. Carlsbad Tech Company Details
Table 107. Carlsbad Tech Business Overview
Table 108. Carlsbad Tech Herpes Simplex Virus Infection Treatment Product
Table 109. Carlsbad Tech Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021) & (US$ Million)
Table 110. Carlsbad Tech Recent Development
Table 111. Avet Pharmaceuticals Inc Company Details
Table 112. Avet Pharmaceuticals Inc Business Overview
Table 113. Avet Pharmaceuticals Inc Herpes Simplex Virus Infection Treatment Product
Table 114. Avet Pharmaceuticals Inc Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021) & (US$ Million)
Table 115. Avet Pharmaceuticals Inc Recent Development
Table 116. Glenmark Pharmaceuticals Company Details
Table 117. Glenmark Pharmaceuticals Business Overview
Table 118. Glenmark Pharmaceuticals Herpes Simplex Virus Infection Treatment Product
Table 119. Glenmark Pharmaceuticals Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021) & (US$ Million)
Table 120. Glenmark Pharmaceuticals Recent Development
Table 121. Fresenius Kabi Company Details
Table 122. Fresenius Kabi Business Overview
Table 123. Fresenius Kabi Herpes Simplex Virus Infection Treatment Product
Table 124. Fresenius Kabi Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021) & (US$ Million)
Table 125. Fresenius Kabi Recent Development
Table 126. Agenus, Inc Company Details
Table 127. Agenus, Inc Business Overview
Table 128. Agenus, Inc Herpes Simplex Virus Infection Treatment Product
Table 129. Agenus, Inc Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021) & (US$ Million)
Table 130. Agenus, Inc Recent Development
Table 131. Maruho Co. Ltd Company Details
Table 132. Maruho Co. Ltd Business Overview
Table 133. Maruho Co. Ltd Herpes Simplex Virus Infection Treatment Product
Table 134. Maruho Co. Ltd Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021) & (US$ Million)
Table 135. Maruho Co. Ltd Recent Development
Table 136. AiCuris Anti-infective Cures GmbH Company Details
Table 137. AiCuris Anti-infective Cures GmbH Business Overview
Table 138. AiCuris Anti-infective Cures GmbH Herpes Simplex Virus Infection Treatment Product
Table 139. AiCuris Anti-infective Cures GmbH Revenue in Herpes Simplex Virus Infection Treatment Business (2016-2021) & (US$ Million)
Table 140. AiCuris Anti-infective Cures GmbH Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Herpes Simplex Virus Infection Treatment Market Share by Type: 2020 VS 2027
Figure 2. Herpes Simplex Virus-1 (HSV-1) Infection Features
Figure 3. Herpes Simplex Virus-2 (HSV-2) Infection Features
Figure 4. HSV1 & HSV2 Co-infection Features
Figure 5. Global Herpes Simplex Virus Infection Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Online Pharmacies Case Studies
Figure 9. Herpes Simplex Virus Infection Treatment Report Years Considered
Figure 10. Global Herpes Simplex Virus Infection Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Herpes Simplex Virus Infection Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Herpes Simplex Virus Infection Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Herpes Simplex Virus Infection Treatment Market Share by Regions (2022-2027)
Figure 14. Global Herpes Simplex Virus Infection Treatment Market Share by Players in 2020
Figure 15. Global Top Herpes Simplex Virus Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herpes Simplex Virus Infection Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Herpes Simplex Virus Infection Treatment Revenue in 2020
Figure 17. Global Herpes Simplex Virus Infection Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Herpes Simplex Virus Infection Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Herpes Simplex Virus Infection Treatment Market Share by Type (2016-2027)
Figure 21. North America Herpes Simplex Virus Infection Treatment Market Share by Application (2016-2027)
Figure 22. North America Herpes Simplex Virus Infection Treatment Market Share by Country (2016-2027)
Figure 23. United States Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Herpes Simplex Virus Infection Treatment Market Share by Type (2016-2027)
Figure 27. Europe Herpes Simplex Virus Infection Treatment Market Share by Application (2016-2027)
Figure 28. Europe Herpes Simplex Virus Infection Treatment Market Share by Country (2016-2027)
Figure 29. Germany Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Herpes Simplex Virus Infection Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Herpes Simplex Virus Infection Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Herpes Simplex Virus Infection Treatment Market Share by Region (2016-2027)
Figure 39. China Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Herpes Simplex Virus Infection Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Herpes Simplex Virus Infection Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Herpes Simplex Virus Infection Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2016-2021)
Figure 59. Sanofi Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2016-2021)
Figure 60. Teva Pharmaceuticals Inc Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2016-2021)
Figure 61. Merck & Co., Inc Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2016-2021)
Figure 62. Apotex Inc Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2016-2021)
Figure 63. Viatris Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2016-2021)
Figure 64. Epi Health LLC Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2016-2021)
Figure 65. Zydus Pharmaceuticals Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2016-2021)
Figure 66. GlaxoSmithKline LLC Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2016-2021)
Figure 67. Carlsbad Tech Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2016-2021)
Figure 68. Avet Pharmaceuticals Inc Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2016-2021)
Figure 69. Glenmark Pharmaceuticals Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2016-2021)
Figure 70. Fresenius Kabi Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2016-2021)
Figure 71. Agenus, Inc Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2016-2021)
Figure 72. Maruho Co. Ltd Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2016-2021)
Figure 73. AiCuris Anti-infective Cures GmbH Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
Keyplayers in Global Herpes Simplex Virus Infection Treatment Market Size, Status and Forecast 2021-2027
F. Hoffmann-La Roche LtdSanofi
Teva Pharmaceuticals Inc
Merck & Co., Inc
Apotex Inc
Viatris
Epi Health LLC
Zydus Pharmaceuticals
GlaxoSmithKline LLC
Carlsbad Tech
Avet Pharmaceuticals Inc
Glenmark Pharmaceuticals
Fresenius Kabi
Agenus, Inc
Maruho Co. Ltd
AiCuris Anti-infective Cures GmbH
